Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration

The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain

A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and small molecule drugs)

T-cell immunotherapy developers were observed to be primarily focused on the treatment of different oncological indications.

Around 50% of the vascular disrupting agents are being evaluated in phase II clinical trials, while more than 5%

It is currently dominated by the presence of mid-sized players (51-500 employees), which represent more than 55% of industry stakeholders

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential

An in-depth analysis of the various patents that have been filed / granted related to neoantigens till April 2019

The report features an extensive study on the current market landscape and future of companies offering services

Our Hyper-targeted prospect database helps businesses to reach their prospects through email marketing, telemarketing, direct marketing, and social media and increases ROI of demand generation and lead generation campaigns.

T-cell immunotherapy developers were observed to be primarily focused on the treatment of different oncological indications.

Over time, ~15 cell and gene therapies have been approved across the world. Since transgene delivery into biological producing cell lines

Advances in screening technologies have enabled the identification of interactive gene combinations

The most common misunderstanding regarding the role of these third-party participants is that they are there to manage careers. It is frequently the cause of

A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes